ABB Stock Up On Higher Q1 Opn. EBITA, Boost In FY24 Margin View

RTTNews | 34 ngày trước
ABB Stock Up On Higher Q1 Opn. EBITA, Boost In FY24 Margin View

(RTTNews) - Shares of ABB Ltd. were gaining around 6 percent in the morning trading in Switzerland after the Swiss engineering company on Thursday reported higher Operational EBITA, a key earnings metric, in its first quarter. Meanwhile, net profit and orders were lower and revenues were nearly flat. The company said its order intake for the first quarter was better than expected.

Looking ahead for the second quarter, the company anticipates a mid-single digit comparable revenue growth year-on-year and the Operational EBITA margin to be slightly higher than in the first quarter 2024.

Further, ABB now expects fiscal 2024 operational EBITA margin of about 18 percent, while previously it expected slight improvement from the 2023 level of 16.9 percent. ABB continues to expect comparable revenue growth to be about 5 percent for the year.

Bjorn Rosengren, CEO, said, "Against high comparables, our Q1 performance shows the year has started off well with stronger than expected order momentum, record-high margin and strong cash delivery. This makes us confident to nudge up our margin expectation for 2024."

In its first quarter, ABB's net income attributable was $905 million, down 13 percent from last year's $1.04 billion. Basic earnings per share fell 12 percent to $0.49 from $0.56 a year ago. The net income were lower as last year's results were benefited by low tax rate.

Income from operations, however, grew 2 percent year-on-year to $1.22 billion. Margin on Income from operations was 15.5 percent, up by 30 basis points year-on-year.

Operational EBITA grew 11 percent to $1.42 billion. Operational EBITA margin improved 1.6 percentage points from last year to 17.9 percent. Gross profit improved 8 percent from the prior year to $2.94 billion and gross margin grew 2.7 percentage points to 37.3 percent, supported by a positive development in all business areas.

Revenues remained stable at $7.87 billion, compared to prior year's $7.86 billion. Strong growth in Electrification and Process Automation were offset by weakness in Motion and Robotics & Discrete Automation.

Revenues were up 2 percent on a comparable basis, with comparable growth supported in equal parts by price and volumes.

Orders fell 5 percent to $8.97 billion from last year's $9.45 billion. On a comparable basis, orders declined 4 percent.

Orders in the Americas dropped by 3 percent as a positive comparable development in the United States was offset by declines elsewhere and mainly due to the timing of large orders. Europe declined by 8 percent weighed down by important markets like Germany and Italy. Asia, Middle East and Africa orders fell 4 percent as strong comparable development in countries like India, Japan and Australia were offset by a sharp decline in China.

In Switzerland, ABB shares were trading at 44.09 Swiss francs, up 5.7 percent.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

read more
ABB Stock Down On Weak Q3 Orders, Q4 Margin Warning

ABB Stock Down On Weak Q3 Orders, Q4 Margin Warning

Swiss engineering company ABB Ltd. reported Wednesday significantly higher profit in its third quarter with strong revenue growth, while orders were weak. Going ahead, the company projects comparable revenue growth in the fourth quarter, but margin will be lower sequentially. The company further lifted its forecast for fiscal 2023. In Switzerland, ABB shares were losing around 5 percent.
RTTNews | 217 ngày trước
ABB Stock Up On Surge In Q2 Profit, Positive Outlook

ABB Stock Up On Surge In Q2 Profit, Positive Outlook

Shares of ABB Ltd. were gaining around 3 percent in the morning trading in Switzerland after the Swiss engineering company reported Thursday significantly higher profit in its second quarter on strong revenue growth. Orders, meanwhile, declined from last year. Looking ahead, the company said it sees growth in its third quarter, and maintained revenue forecast for fiscal 2023.
RTTNews | 307 ngày trước
U.S. Existing Home Sales Unexpectedly Extend Pullback In April

U.S. Existing Home Sales Unexpectedly Extend Pullback In April

Existing home sales in the U.S. unexpectedly saw further downside in the month of April, according to a report released by the National Association of Realtors on Wednesday. NAR said existing home sales slumped by 1.9 percent to an annual rate of 4.14 million in April after tumbling by 3.7 percent to a revised rate of 4.22 million in March.
RTTNews | 5h 13phút trước
Hovnanian Enterprises Net Profit Rises 48.9%

Hovnanian Enterprises Net Profit Rises 48.9%

Homebuilder Hovnanian Enterprises Inc. (HOV) reported Wednesday that net income for the second quarter increased 48.9 percent to $50.8 million or $6.66 per share from $34.1 million or $4.47 per share in the prior-year quarter.
RTTNews | 5h 35phút trước
Anglo American And BHP Major Shareholder PIC Demands Substantial Revision Of BHP Proposal For Anglo

Anglo American And BHP Major Shareholder PIC Demands Substantial Revision Of BHP Proposal For Anglo

Public Investment Corp. or PIC, a major shareholder of both Anglo American plc (AAUKY.PK, AAL.L) and BHP Group (BHP), on Wednesday said it requires a meaningful revision of the current BHP proposal for Anglo American to "reflect both the embedded value of existing Anglo assets and the future optionality and benefits that BHP can derive, specifically from Anglo's unlisted assets."
RTTNews | 6h 32phút trước
Bay Street Likely To Open Lower

Bay Street Likely To Open Lower

Canadian shares are likely to open on a slightly negative note Wednesday morning as energy and materials sectors may find the going somewhat tough due to weak commodity prices.
RTTNews | 7h 21phút trước
Biogen To Buy Human Immunology Biosciences In Deal Valued At Up To $1.8 Bln

Biogen To Buy Human Immunology Biosciences In Deal Valued At Up To $1.8 Bln

Biogen Inc. (BIIB) and privately-held biotechnology company Human Immunology Biosciences or HI-Bio, announced Wednesday the companies have entered into a definitive agreement under which Biogen has agreed to acquire HI-Bio for $1.15 billion upfront and up to $650 million in potential milestone payments.
RTTNews | 7h 23phút trước